Modulation of recombinant, α2*, α3* or α4*-nicotinic acetylcholine receptor (nAChR) function by nAChR β3 subunits

Journal of Neurochemistry

Volumn 121, Issue 3, 2012, Pages 349-361

  Dash, Bhagirathi ^a,b   Bhakta, Minoti ^a   Chang, Yongchang ^a   Lukas, Ronald J ^a  

^a BARROW NEUROLOGICAL INSTITUTE   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

Author keywords

ligand gated ion channel; nicotinic acetylcholine receptor(s); receptor structure function

Indexed keywords

ACETYLCHOLINE; ATROPINE; NICOTINE; NICOTINIC RECEPTOR; NICOTINIC RECEPTOR ALPHA2; NICOTINIC RECEPTOR ALPHA3; NICOTINIC RECEPTOR ALPHA4; NICOTINIC RECEPTOR BETA2; NICOTINIC RECEPTOR BETA3; NICOTINIC RECEPTOR BETA4; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CHANNEL GATING; COMPLEX FORMATION; CONTROLLED STUDY; FEMALE; NONHUMAN; OOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; XENOPUS;

ACETYLCHOLINE; ANIMALS; ATROPINE; CLONING, MOLECULAR; DATA INTERPRETATION, STATISTICAL; FEMALE; HUMANS; ION CHANNEL GATING; MUSCARINIC ANTAGONISTS; MUTAGENESIS; MUTATION; NICOTINE; NICOTINIC AGONISTS; OOCYTES; PATCH-CLAMP TECHNIQUES; PLASMIDS; RECEPTORS, NICOTINIC; RNA, COMPLEMENTARY; TRANSCRIPTION, GENETIC; XENOPUS; XENOPUS PROTEINS;

EID: 84862779353     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2012.07685.x     Document Type: Article

References (32)

1. Baker E. R., Zwart R., Sher E., and, Millar N. S., (2004) Pharmacological properties of α9 α10 nicotinic acetylcholine receptors revealed by heterologous expression of subunit chimeras. Mol. Pharmacol. 65, 453-460.
2. Boorman J. P., Groot-Kormelink P. J., and, Sivilotti L. G., (2000) Stoichiometry of human recombinant neuronal nicotinic receptors containing the b3 subunit expressed in Xenopus oocytes. J. Physiol., 529 (Pt 3), 565-577.
3. Boorman J. P., Beato M., Groot-Kormelink P. J., Broadbent S. D., and, Sivilotti L. G., (2003) The effects of β3 subunit incorporation on the pharmacology and single channel properties of oocyte-expressed human α3β4 neuronal nicotinic receptors. J. Biol. Chem. 278, 44033-44040.
4. Broadbent S., Groot-Kormelink P. J., Krashia P. A., Harkness P. C., Millar N. S., Beato M., and, Sivilotti L. G., (2006) Incorporation of the beta3 subunit has a dominant-negative effect on the function of recombinant central-type neuronal nicotinic receptors. Mol. Pharmacol. 70, 1350-1357.
5. Carbone A. L., Moroni M., Groot-Kormelink P. J., and, Bermudez I., (2009) Pentameric concatenated (α4)(2)(β2)(3) and (α4)(3)(β2)(2) nicotinic acetylcholine receptors: subunit arrangement determines functional expression. Br. J. Pharmacol. 156, 970-981.
6. Chang Y., and, Weiss D. S., (1998) Substitutions of the highly conserved M2 leucine create spontaneously opening rho1 gamma-aminobutyric acid receptors. Mol. Pharmacol. 53, 511-523.
7. Chavez-Noriega L. E., Crona J. H., Washburn M. S., Urrutia A., Elliott K. J., and, Johnson E. C., (1997) Pharmacological characterization of recombinant human neuronal nicotinic acetylcholine receptors h α2 β2, h α2 β4, h α3 β2, h α3 β4, h α4 β2, h α4 β4 and h α7 expressed in Xenopus oocytes. J. Pharmacol. Exp. Ther. 280, 346-356.
8. Cui C., Booker T. K., and, Allen R. S., et al. (2003) The β3 nicotinic receptor subunit: a component of α-conotoxin MII-binding nicotinic acetylcholine receptors that modulate dopamine release and related behaviors. J. Neurosci. 23, 11045-11053.
9. Dash B., Bhakta M., Chang Y., and, Lukas R. J., (2011a) Identification of N-terminal, extracellular domain determinants in nicotinic acetylcholine receptor (nAChR) {α}6 subunits that influence effects of wild-type or mutant {β}3 subunits on function of {α}6{β}2*-or {α}6{β}4*-nAChR. J. Biol. Chem. 286, 37976-37989.
10. Dash B., Chang Y., and, Lukas R. J., (2011b) Reporter mutation studies show that nicotinic acetylcholine receptor (nAChR) {α}5 subunits and/or variants modulate function of {α}6*-nAChRs. J. Biol. Chem. 286, 37905-37918.
11. Gotti C., Moretti M., Zanardi A., et al. (2005) Heterogeneity and selective targeting of neuronal nicotinic acetylcholine receptor (nAChR) subtypes expressed on retinal afferents of the superior colliculus and lateral geniculate nucleus: identification of a new native nAChR subtype α3β2(α5 or β3) enriched in retinocollicular afferents. Mol. Pharmacol. 68, 1162-1171.
12. Grady S. R., Moretti M., Zoli M., Marks M. J., Zanardi A., Pucci L., Clementi F., and, Gotti C., (2009) Rodent habenulo-interpeduncular pathway expresses a large variety of uncommon nAChR subtypes, but only the α3β4* and α3β3β4* subtypes mediate acetylcholine release. J. Neurosci. 29, 2272-2282.
13. Groot Kormelink P. J., and, Luyten W. H., (1997) Cloning and sequence of full-length cDNAs encoding the human neuronal nicotinic acetylcholine receptor (nAChR) subunits beta3 and beta4 and expression of seven nAChR subunits in the human neuroblastoma cell line SH-SY5Y and/or IMR-32. FEBS Lett. 400, 309-314.
14. Groot-Kormelink P. J., Luyten W. H., Colquhoun D., and, Sivilotti L. G., (1998) A reporter mutation approach shows incorporation of the "orphan" subunit beta3 into a functional nicotinic receptor. J. Biol. Chem. 273, 15317-15320.
15. Groot-Kormelink P. J., Boorman J. P., and, Sivilotti L. G., (2001) Formation of functional α3β4α5 human neuronal nicotinic receptors in Xenopus oocytes: a reporter mutation approach. Br. J. Pharmacol. 134, 789-796.
16. Kuryatov A., Onksen J., and, Lindstrom J., (2008) Roles of accessory subunits in α4β2 nicotinic receptors. Mol. Pharmacol. 74, 132-143.
17. Luetje C. W., (2004) Getting past the asterisk: the subunit composition of presynaptic nicotinic receptors that modulate striatal dopamine release. Mol. Pharmacol. 65, 1333-1335.
18. Luetje C. W., and, Patrick J., (1991) Both α- and β-subunits contribute to the agonist sensitivity of neuronal nicotinic acetylcholine receptors. J. Neurosci. 11, 837-845.
19. Lukas R. J., Changeux J. P., and, Le Novere N., et al. (1999) International Union of Pharmacology. XX. Current status of the nomenclature for nicotinic acetylcholine receptors and their subunits. Pharmacol. Rev. 51, 397-401.
20. Nelson M. E., Wang F., Kuryatov A., Choi C. H., Gerzanich V., and, Lindstrom J., (2001) Functional properties of human nicotinic AChRs expressed by IMR-32 neuroblastoma cells resemble those of α3β4 AChRs expressed in permanently transfected HEK cells. J. Gen. Physiol. 118, 563-582.
21. Nelson M. E., Kuryatov A., Choi C. H., Zhou Y., and, Lindstrom J., (2003) Alternate stoichiometries of α4β2 nicotinic acetylcholine receptors. Mol. Pharmacol. 63, 332-341.
22. Palma E., Maggi L., Barabino B., Eusebi F., and, Ballivet M., (1999) Nicotinic acetylcholine receptors assembled from the α7 and β3 subunits. J. Biol. Chem. 274, 18335-18340.
23. Paradiso K. G., and, Steinbach J. H., (2003) Nicotine is highly effective at producing desensitization of rat α4β2 neuronal nicotinic receptors. J. Physiol. 553, 857-871.
24. Parker J. C., Sarkar D., Quick M. W., and, Lester R. A., (2003) Interactions of atropine with heterologously expressed and native α3 subunit-containing nicotinic acetylcholine receptors. Br. J. Pharmacol. 138, 801-810.
25. Picciotto M. R., Caldarone B. J., Brunzell D. H., Zachariou V., Stevens T. R., and, King S. L., (2001) Neuronal nicotinic acetylcholine receptor subunit knockout mice: physiological and behavioral phenotypes and possible clinical implications. Pharmacol. Ther. 92, 89-108.
26. Salminen O., Murphy K. L., McIntosh J. M., Drago J., Marks M. J., Collins A. C., and, Grady S. R., (2004) Subunit composition and pharmacology of two classes of striatal presynaptic nicotinic acetylcholine receptors mediating dopamine release in mice. Mol. Pharmacol. 65, 1526-1535.
27. Sheffield E. B., Quick M. W., and, Lester R. A., (2000) Nicotinic acetylcholine receptor subunit mRNA expression and channel function in medial habenula neurons. Neuropharmacology 39, 2591-2603.
28. Tapia L., Kuryatov A., and, Lindstrom J., (2007) Ca2 + permeability of the (α4)3(β2)2 stoichiometry greatly exceeds that of (α4)2(β2)3 human acetylcholine receptors. Mol. Pharmacol. 71, 769-776.
29. Yu K. D., Liu Q., Wu J., and, Lukas R. J., (2009) Kinetics of desensitization and recovery from desensitization for human α4β2- nicotinic acetylcholine receptors stably expressed in SH-EP1 cells. Acta Pharmacol. Sin. 30, 805-817.
30. Zwart R., and, Vijverberg H. P., (1997) Potentiation and inhibition of neuronal nicotinic receptors by atropine: competitive and noncompetitive effects. Mol. Pharmacol. 52, 886-895.
31. Zwart R., and, Vijverberg H. P., (1998) Four pharmacologically distinct subtypes of α4β2 nicotinic acetylcholine receptor expressed in Xenopus laevis oocytes. Mol. Pharmacol. 54, 1124-1131.
32. Zwart R., Van Kleef R. G., and, Vijverberg H. P., (1999) Physostigmine and atropine potentiate and inhibit neuronal α4 β4 nicotinic receptors. Ann. N Y Acad. Sci. 868, 636-639.